Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
they just replaced him
with mr Corbett
I’m less concerned with the sweet deal Hrusovsky is getting and more concerned with the fact that he’s leaving the company, which suggest to me that PKI’s Caliper business is not doing as well as he expected when he agreed to be acquired.
HOW CAN I GET A DEAL LIKE THIS?
Hrusovsky will work approximately 8 hours per week and be paid at a rate of $20,833 per month
E. Kevin Hrusovsky, Senior Vice President and President, Life Sciences and Technology of PerkinElmer, Inc. (the “Company”) informed the Company on May 7, 2013 that he was resigning from the Company effective as of May 31, 2013. The Company and Mr. Hrusovsky have agreed that as a result of this resignation, Mr. Hrusovsky will be entitled to the benefits associated with a “Constructive Termination Upon Change of Control” under the Caliper Life Sciences, Inc. Key Employee Change of Control and Severance Benefit Plan, as amended and restated as of December 8, 2010, and as further modified by a letter agreement between Mr. Hrusovsky and the Company dated December 12, 2012. The Company and Mr. Hrusovsky entered into a Consulting Agreement (the “Agreement”) on May 10, 2013 whereby Mr. Hrusovsky will provide consulting services to the Company beginning on June 1, 2013 for a period of up to one year. Under the Agreement, Mr. Hrusovsky will work approximately 8 hours per week and be paid at a rate of $20,833 per month. Either party can terminate the Agreement on 30 days prior written notice.
HOW CAN I GET A DEAL LIKE THIS?
E. Kevin Hrusovsky, Senior Vice President and President, Life Sciences and Technology of PerkinElmer, Inc. (the “Company”) informed the Company on May 7, 2013 that he was resigning from the Company effective as of May 31, 2013. The Company and Mr. Hrusovsky have agreed that as a result of this resignation, Mr. Hrusovsky will be entitled to the benefits associated with a “Constructive Termination Upon Change of Control” under the Caliper Life Sciences, Inc. Key Employee Change of Control and Severance Benefit Plan, as amended and restated as of December 8, 2010, and as further modified by a letter agreement between Mr. Hrusovsky and the Company dated December 12, 2012. The Company and Mr. Hrusovsky entered into a Consulting Agreement (the “Agreement”) on May 10, 2013 whereby Mr. Hrusovsky will provide consulting services to the Company beginning on June 1, 2013 for a period of up to one year. Under the Agreement, Mr. Hrusovsky will work approximately 8 hours per week and be paid at a rate of $20,833 per month. Either party can terminate the Agreement on 30 days prior written notice.
When all is said and done, split-ups rarely add shareholder value because there are substantial one-time costs (including banking fees) from implementing the separation.
If a suitor were interested in acquiring part of PKI, it could bid for that part of the company directly (or buy the whole company and divest the part it didn’t want). In other words, by staying as one company, PKI isn’t squelching interest in a possible takeover.
Unlikely, IMO. PKI has never talked about a split-up.
The recent insider sales were under 10b5-1 selling plans, which are a major scam, IMO—see #msg-87085786.
Unfortunately, many biotech executives and directors have them.
Many insiders may need to explain why they were selling up to the release!!!!!!!!
8m shares dumped
also 8 m shares bought
we may see who...soon
Musings on the 1Q13 EPS/revenue miss: #msg-87298954.
i will be lissening
CC starts in 10 minutes. They're gonna have some explaining to do.
looks bad to me...36c vs 48?
After Hours : 30.50 Down 3.97 (11.52%)
http://ih.advfn.com/p.php?pid=nmona&article=57329121
first time that i noticed...
closing two days at the high of the day..
good?
way overdone on the selling
on the other end
they pushed TMO up because some analist said that TMO was too conservative on their guiding....
you figure
Reuters 4Q12 write-up with some annotations by me:
#msg-84108958
Life may be too expensive for them
they can have pki for half
yes pki for half of Life.$$$$.or 60 $$$$$..nice
Weren’t you just talking about LIFE? See #msg-83962602.
http://stockcharts.com/h-sc/ui?s=pki
target 49.50 on the Gallery viuw
very nice
takeover soon?
The MF write-up is a throwaway, IMO; here's a better one: #msg-83451363 :- )
SOUND GOOD
TELL THEM ABOUT US..PKI...PKI...LOL
You be the judge after listening to ABT’s JPM presentation (only 15 minutes):
http://jpmorgan.metameetings.com/webcasts/healthcare13/webcast_of.php?p=10843
no money short there
52b cap...bring=that onnnn
http://ih.advfn.com/p.php?pid=squote&symbol=abt
New 13G filing—Shapiro Capital Mgmt owns a 4.9% equity stake (5.6M sh):
http://www.sec.gov/Archives/edgar/data/31791/000090901213000004/t306949.txt
Morgan Stanley upgraded PerkinElmer to "overweight" from "equal weight," sending shares of the environmental health company higher in extended-hours trading. Meanwhile, the brokerage firm downgraded Waters to "equal-weight" from "overweight," sending shares of the laboratory software company lower in extended-hours trading.
Support 2 Support 1 Pivot Price Resistance 1 Resistance 2
$ 31.5833 $ 31.9367 $ 32.1733 $ 32.5267 $ 32.7633
Shares Short (as of Nov 30, 2012)
3.64M
thanks
any target?
Merrill Lynch: PKI is one of top healthcare picks for 2013. FWIW
Re: PKI acquires Shanghai Haoyuan Biotech
Good catch—I reposted with the deal price ($38M plus considerations): #msg-81421950. Regards, Dew
this should improve even better our strong presence there
was for 38m$$$
The 3Q12 10-Q has been filed:
http://www.sec.gov/Archives/edgar/data/31791/000144530512003461/pki-9302012x10q.htm
Followers
|
2
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
467
|
Created
|
04/11/08
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |